U.S.A CLINICAL RESEARCHER OF THE YEAR
April 11, 2011 - Anna Parker - Beardsworth Citation for Patient Focus
POSTER PRESENTATION: ISRVI 2011
March 12-15, 2011, Cairo Egypt - The Q-pan 010 abstract entitled "Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 months" by George Risi, Louise Frenette, Joanne M. Langley, Ping Li, Dennis Riff, Eric Sheldon, David W. Vaughn, and Louis Fries has been ACCEPTED for a poster presentation at the ISRVI 2011 congress.
MANUSCRIPT ACCEPTED BY JOURNAL OF INFECTIOUS DISEASES: "Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: A phase III, placebo-controlled, randomized study "
January 25, 2011 - The manuscript entitled: "Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: A phase III, placebo-controlled, randomized study " by Joanne M. Langley, George Risi, Michael Caldwell, Larry Gilderman, Bruce Berwald, Charles Fogarty, Terry Poling, Dennis Riff, Mira Baron, Louise Frenette, Eric Sheldon, Harry Collins, Marc Shepard, Marc Dionne, Daniel Brune, Linda Ferguson, David Vaughn, Ping Li, and Louis Fries and reporting the results from the QPAN-002 trial has been accepted by the Journal of Infectious Diseases.
PRESS RELEASE: Advanced Clinical Research Institute, LLC Celebrates
10 years of Early Clinical Research with the Grand Opening of its
New Clinical Pharmacology Unit
March 13, 2009 - Advanced Clinical
Research Institute (ACRI), one of the largest, privately-owned Phase
I through Phase IV Clinical Research Facilities in the US, announced
the opening of its new Phase I, Clinical Pharmacology Unit (CPU) located
at 1085 North Harbor Boulevard, Anaheim, CA. The new, 10,000 square foot,
overnight facility with 40-bed capacity, offers private sleeping quarters
and examination rooms, separate dining and entertainment areas, and enclosed
outdoor patio.
PRESS RELEASE: Advanced Clinical Research Institute and Clinesian
Announce Strategic Partnership
August 25, 2008 - Advanced Clinical Research Institute (ACRI),
a Phase I through Phase IV clinical research center, today announced a strategic
partnership with Clinesian, a boutique global CRO. The partnership enables a seamless
integration of study conduct with full CRO services, including project management,
monitoring, quality assurance, data management, biostatistics, and medical writing.
Both companies are located in southern California.